CRVS ▼ -0.5% - Corvus Pharmaceuticals, Inc.
$CRVS - Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa
30-SEP-2026 04:06 PM ET
Share this post
More filings for $CRVS
CRVS ▼ -0.3% - Corvus Pharmaceuticals, Inc.Sep 3, 2026CRVS ▼ -0.6% - Corvus Pharmaceuticals, Inc.Aug 27, 2026CRVS - Corvus Pharmaceuticals, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026$CRVS SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 27, 2026
View full $CRVS filing history →💬 Comments
Loading comments…
Leave a comment